Business Description
Island Pharmaceuticals Ltd
ISIN : AU0000138869
Description
Island Pharmaceuticals Ltd is a drug research and repurposing company focused on developing preventative or therapeutic drugs for viral infections. Its drug candidate ISLA-101 is a drug with a well-established safety profile, being repurposed for the prevention and treatment of dengue fever and another mosquito (or vector) borne diseases. The company carries out its research and development activities principally in the geographic regions of Australia and the United States of America.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.92 | |||||
| Equity-to-Asset | 0.36 | |||||
| Debt-to-Equity | 0.8 | |||||
| Debt-to-EBITDA | -0.22 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | -3.29 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 9.39 | |||||
| 9-Day RSI | 22.01 | |||||
| 14-Day RSI | 29.03 | |||||
| 6-1 Month Momentum % | -2.1 | |||||
| 12-1 Month Momentum % | -23.98 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.57 | |||||
| Quick Ratio | 1.57 | |||||
| Cash Ratio | 0.87 | |||||
| Days Sales Outstanding | 564.09 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -6.63 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -26336.36 | |||||
| Net Margin % | -25727.27 | |||||
| FCF Margin % | -24781.82 | |||||
| ROE % | -133.7 | |||||
| ROA % | -96.3 | |||||
| ROIC % | -1288.1 | |||||
| ROC (Joel Greenblatt) % | -1389.41 | |||||
| ROCE % | -132.97 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 7.57 | |||||
| Price-to-Tangible-Book | 5.3 | |||||
| EV-to-EBIT | -2.36 | |||||
| EV-to-EBITDA | -2.36 | |||||
| EV-to-Revenue | 505.73 | |||||
| EV-to-FCF | -2.04 | |||||
| Price-to-Net-Current-Asset-Value | 5.3 | |||||
| Price-to-Net-Cash | 2.65 | |||||
| Earnings Yield (Greenblatt) % | -42.37 | |||||
| FCF Yield % | -45.2 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Island Pharmaceuticals Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil A$) | 0.011 | ||
| EPS (TTM) (A$) | -0.027 | ||
| Beta | 0.75 | ||
| Volatility % | 88.27 | ||
| 14-Day RSI | 29.03 | ||
| 14-Day ATR (A$) | 0.002551 | ||
| 20-Day SMA (A$) | 0.05905 | ||
| 12-1 Month Momentum % | -23.98 | ||
| 52-Week Range (A$) | 0.05 - 0.134642 | ||
| Shares Outstanding (Mil) | 113.8 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Island Pharmaceuticals Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Island Pharmaceuticals Ltd Stock Events
| Event | Date | Price(A$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Island Pharmaceuticals Ltd Frequently Asked Questions
What is Island Pharmaceuticals Ltd(ASX:ILA)'s stock price today?
The current price of ASX:ILA is A$0.05. The 52 week high of ASX:ILA is A$0.13 and 52 week low is A$0.05.
When is next earnings date of Island Pharmaceuticals Ltd(ASX:ILA)?
The next earnings date of Island Pharmaceuticals Ltd(ASX:ILA) is .
Does Island Pharmaceuticals Ltd(ASX:ILA) pay dividends? If so, how much?
Island Pharmaceuticals Ltd(ASX:ILA) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers